Skip to main content
Jamie Frediani, MD, Pediatric Hematology & Oncology, Orange, CA

JamieNFredianiMD

Pediatric Hematology & Oncology • Orange, CA

Physician

Join to view full profile

Dr. Frediani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Frediani's full profile

Already have an account?

  • Office

    1201 W La Veta Ave
    Orange, CA 92868
    Phone+1 714-509-8636
    Fax+1 714-509-8699

Education & Training

  • Children's Hospital Los Angeles
    Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2014 - 2017
  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2011 - 2014
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 2011
  • University of California, Davis
    University of California, DavisBS, Microbiology, minor in Nutrition Science, High Honors, 2003 - 2007

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - 2025
  • OH State Medical License
    OH State Medical License 2011 - 2015
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Best Poster Winner in Basic Science Research The Saban Research Institute (22nd Annual Poster Session), 2017
  • Kurt Ian Wey, MD Pediatrics Award 2011
  • Alpha Omega Alpha, Junior Member 2010
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Essential role of miRNAs in orchestrating the biology of the tumor microenvironment  
    Frediani, J.N., & Fabbri, M., Molecular Cancer, 1/1/2016
  • Question 2: Does the timing of central line placement in relationship to the initiation of acute lymphoblastic leukaemia therapy change the risk of thrombosis or infec...  
    Frediani, J. N., & Phillips, B., Archives of Disease in Childhood, 1/1/2015
  • The safety of cefepime and ceftazidime in pediatric oncology patients  
    Hoffman, J. M., Frediani, J., Herr, M., Flynn, P. M., & Adderson, E. E., Pediatric Blood & Cancer, 1/1/2013

Abstracts/Posters

  • Endothelial Cell Derived Exosomes Increase Migration of Cancer Cells.
    Frediani J, Neviani P, Wise P, Murtadha M, Fabbri M, The Saban Research Institute's 22nd Annual Poster Session, Children's Hospital Los Angeles, 1/6/2017
  • Scheduled Chemotherapy Admissions: Decreasing the time from Admission to Chemotherapy Initiation.
    Frediani J, Adam E, Maruffi M, Yeo K, Children's Hospital Los Angeles Hospital Quality Improvement Research Day, 1/1/2015
  • Timing of line placement in children with Acute Lymphoblastic Leukemia and the effect on the risk of central line related thrombosis and infection.
    Frediani J, Phillips B, 33rd Annual Edward L. Pratt Lectures, Cincinnati Children's Hospital Medical Center, 1/21/2014
  • Join now to see all

Lectures

  • Methemoglobinemia 
    Children's Hospital Los Angeles - 1/29/2017
  • Disseminated Fusarium Infection in the setting of Active Leukemia Treatment. 
    1/26/2017
  • The Interaction of Endothelial Cells and Neuroblastoma in the Tumor Microenvironment 
    Children's Hospital Los Angeles - 1/3/2017
  • Join now to see all

Dr. Jamie Frediani, Dr. Jamie Frediani, MD, Dr. J Frediani, Dr. Jamie N Frediani